 |
| |
| For Immediate Release |
| |
Prodesse
Begins Clinical Trial for ProFlu+
A Multiplex PCR Assay for Detection of Key Respiratory Viruses
WAUKESHA, WI (February 12, 2007) – Prodesse, Inc. announced today
that several leading healthcare institutions have begun clinical trials
of its recently developed ProFlu+, a multiplex PCR assay for the detection
and differentiation of Influenza A virus, Influenza B virus and Respiratory
Syncytial Virus (RSV). Prodesse has worked closely with the FDA on the
clinical study design and expects to submit its application for 510(k)
clearance shortly after completion of clinical trials this spring.
Current FDA cleared methods for detection of these three key respiratory
viruses suffer from a variety of problems – some lack sensitivity,
some lack clinically useful turnaround time and some require subjective
interpretation. Prodesse’s product is intended to address all of
these problems, and it has necessary enzymes incorporated so that labs
will find it very ‘user-friendly’.
Prodesse CEO Tom Shannon commented, “We expect the clinical trials
to show that ProFlu+ is an improvement over the current methodologies used
by labs for detection of these key respiratory viruses. Because our product
is designed for use with existing automated platforms, we expect customers
will find they can dramatically reduce the effort they currently expend
on respiratory virus testing while improving the quality and timeliness
of their results.” |
|
About Prodesse
Prodesse is a biotechnology company focused on developing analyte specific
reagents that can be used by CLIA certified laboratories to develop
assays for detecting infectious disease pathogens. The Company's
reagents incorporate proprietary technology that allows for the detection
of multiple pathogens. Prodesse currently offers nine different multiplex
products covering 33 different organisms. The company’s products
can be used on a variety of detection platforms. The Company sells
its reagents to laboratories throughout the US and the world, and
also operates a CLIA certified laboratory for testing services in
the Midwest area. For more information about Prodesse and its products,
call 888-589-6974 or go to www.prodesse.com.
|
| |
Press Contact:
Andy Shrago, Chief Marketing Officer
Prodesse, Inc.
Phone: (262) 446-0700
Email: ashrago@prodesse.com |
| |
|
| |
|
